GLP-1 weight–loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, and self-harm, …
Source link Thank you for reading this post, don't forget to subscribe!
Weight-loss drugs may lower the risk of depression, anxiety, and self-harm, study finds
GLP-1 weight–loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, and self-harm, …
Source link Thank you for reading this post, don't forget to subscribe!
